P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS

• Roi Gat,
• Miri Neeman,
• Shai Levi,
• Mor Levi,
• Nili Eilati,
• Yotam Bronstein,
• Tamir Shragai,
• Tsipora Neuman,
• Yafit Segman,
• Roy Vitkon,
• Moshe Mittelman,
• Irit Avivi,
• Yakir Moshe

Affiliations

Roi Gat

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel

Miri Neeman

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel

Shai Levi

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel

Mor Levi

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel

Nili Eilati

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel

Yotam Bronstein

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel

Tamir Shragai

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel

Tsipora Neuman

2 Tel Aviv University, Sackler Faculty of medicine, Tel Aviv, Israel

Yafit Segman

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel

Roy Vitkon

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel

Moshe Mittelman

2 Tel Aviv University, Sackler Faculty of medicine, Tel Aviv, Israel

Irit Avivi

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel

Yakir Moshe

1 Tel Aviv Sourasky Medical Center, Department of Hematology, Tel Aviv, Israel